We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Humana (HUM) Closes $2.8B Kindred Hospice Divestment to CD&R
Read MoreHide Full Article
Humana Inc. (HUM - Free Report) recently announced that the company has closed the sale of a majority stake in its Kindred at Home subsidiary’s Hospice and Personal Care segments to Clayton, Dubilier & Rice ("CD&R"), a private equity firm. Per the deal, HUM divested 60% interest for $2.8 billion.
Humana retaining the remaining 40% stake will likely enable it to gain from the standalone company’s long-term success. Proceeds from the transaction are likely to be used in debt repayment and share repurchases. The move is expected to boost efficiency and keep costs down.
Humana, which previously held a 40% minority interest in Kindred at Home, bought the remaining 60% shares for $5.7 billion from TPG Capital or TPG and Welsh, Carson, Anderson & Stowe or WCAS in August 2021. After that, it planned to divest the hospice and personal care divisions, while retaining the more profitable home health segment. The company successfully executed the plan in a short period, which is impressive.
Strategic initiatives like these have carved a growth path for the company. HUM is a regular name in the M&A space. Some of the acquisitions made by the company have helped it achieve long-term growth. These include the purchase of Family Physicians Group, Your Home Advantage, Curo and others. The company also announced its iCare buyout in Wisconsin, which expanded its Medicare business.
Other companies in the Medical - HMOs space like Molina Healthcare, Inc. (MOH - Free Report) and Centene Corporation (CNC - Free Report) also focus on inorganic growth strategies.
Molina Healthcare completed the buyout of the Magellan Complete Care (MCC) line of business of Magellan Health. The transaction served more than 3.6 million members under government-sponsored healthcare programs across 18 states. In early 2022, Molina Healthcare closed the acquisition of Texas Medicaid and Medicare-Medicaid Plan (MMP) contracts and specific operating assets of Cigna Corporation (CI - Free Report) for $60 million in cash. The company also closed other buyouts, such as YourCare and Passport, which led to membership increases. Molina Healthcare acquired AgeWell’s managed long-term care business in New York, which is likely to close in the third quarter of 2022. These buyouts boost the company's portfolio and diversify income.
Centene’s mergers and acquisitions strategy is mainly targeted at expanding the company’s markets and increasing its Medicaid membership. Acquisitions like Community Medical Holdings, MHM Services and Fidelis Care have contributed to its revenues and helped it to expand its capabilities. Centene acquired WellCare in January 2020 and the consolidated entity now has a wider scale and diversification with more than 12 million Medicaid and around 5 million Medicare members. Last year, it spent $185 million on buyouts. The acquisitions and partnerships should bolster the company’s operations, aiding long-term growth.
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
Humana (HUM) Closes $2.8B Kindred Hospice Divestment to CD&R
Humana Inc. (HUM - Free Report) recently announced that the company has closed the sale of a majority stake in its Kindred at Home subsidiary’s Hospice and Personal Care segments to Clayton, Dubilier & Rice ("CD&R"), a private equity firm. Per the deal, HUM divested 60% interest for $2.8 billion.
Humana retaining the remaining 40% stake will likely enable it to gain from the standalone company’s long-term success. Proceeds from the transaction are likely to be used in debt repayment and share repurchases. The move is expected to boost efficiency and keep costs down.
Humana, which previously held a 40% minority interest in Kindred at Home, bought the remaining 60% shares for $5.7 billion from TPG Capital or TPG and Welsh, Carson, Anderson & Stowe or WCAS in August 2021. After that, it planned to divest the hospice and personal care divisions, while retaining the more profitable home health segment. The company successfully executed the plan in a short period, which is impressive.
Strategic initiatives like these have carved a growth path for the company. HUM is a regular name in the M&A space. Some of the acquisitions made by the company have helped it achieve long-term growth. These include the purchase of Family Physicians Group, Your Home Advantage, Curo and others. The company also announced its iCare buyout in Wisconsin, which expanded its Medicare business.
Other companies in the Medical - HMOs space like Molina Healthcare, Inc. (MOH - Free Report) and Centene Corporation (CNC - Free Report) also focus on inorganic growth strategies.
Molina Healthcare completed the buyout of the Magellan Complete Care (MCC) line of business of Magellan Health. The transaction served more than 3.6 million members under government-sponsored healthcare programs across 18 states. In early 2022, Molina Healthcare closed the acquisition of Texas Medicaid and Medicare-Medicaid Plan (MMP) contracts and specific operating assets of Cigna Corporation (CI - Free Report) for $60 million in cash. The company also closed other buyouts, such as YourCare and Passport, which led to membership increases. Molina Healthcare acquired AgeWell’s managed long-term care business in New York, which is likely to close in the third quarter of 2022. These buyouts boost the company's portfolio and diversify income.
Centene’s mergers and acquisitions strategy is mainly targeted at expanding the company’s markets and increasing its Medicaid membership. Acquisitions like Community Medical Holdings, MHM Services and Fidelis Care have contributed to its revenues and helped it to expand its capabilities. Centene acquired WellCare in January 2020 and the consolidated entity now has a wider scale and diversification with more than 12 million Medicaid and around 5 million Medicare members. Last year, it spent $185 million on buyouts. The acquisitions and partnerships should bolster the company’s operations, aiding long-term growth.